Type 1 Diabetes: Advances in Understanding and Treatment 100 Years after the Discovery of Insulin. Read more about Type 1 Diabetes: Advances in Understanding and Treatment 100 Years after the Discovery of Insulin.
The Teplizumab Saga: The Challenge of Not Getting Lost in Clinical Translation. Read more about The Teplizumab Saga: The Challenge of Not Getting Lost in Clinical Translation.
Rebalancing the Immune System to Treat Type 1 Diabetes. Read more about Rebalancing the Immune System to Treat Type 1 Diabetes.
Checkpoint Inhibitor-Induced Autoimmune Diabetes: An Autoinflammatory Disease. Read more about Checkpoint Inhibitor-Induced Autoimmune Diabetes: An Autoinflammatory Disease.
Targeting Hyperactive Ras Signaling in Pediatric Cancer. Read more about Targeting Hyperactive Ras Signaling in Pediatric Cancer.
Osteosarcoma through the Lens of Bone Development, Signaling, and Microenvironment. Read more about Osteosarcoma through the Lens of Bone Development, Signaling, and Microenvironment.
Mutations, Bottlenecks, and Clonal Sweeps: How Environmental Carcinogens and Genomic Changes Shape Clonal Evolution during Tumor Progression. Read more about Mutations, Bottlenecks, and Clonal Sweeps: How Environmental Carcinogens and Genomic Changes Shape Clonal Evolution during Tumor Progression.
Buttons and Zippers: Endothelial Junctions in Lymphatic Vessels. Read more about Buttons and Zippers: Endothelial Junctions in Lymphatic Vessels.
α-Synuclein: Multiple System Atrophy Prions. Read more about α-Synuclein: Multiple System Atrophy Prions.
Mechanistic and Preclinical Insights from Mouse Models of Hematologic Cancer Characterized by Hyperactive Ras. Read more about Mechanistic and Preclinical Insights from Mouse Models of Hematologic Cancer Characterized by Hyperactive Ras.
